| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 May 2025 | 14 May 2025 |
| The Board of Directors in its meeting held on Wednesday, May 14, 2025, has approved the increase of the Authorised Share Capital and consequent alteration of clause V of Memorandum of Association of the Company, subject to the approval of the shareholders. | ||
| Board Meeting | 12 May 2025 | 6 May 2025 |
| Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve the Audited Standalone Financial Results of the Company for the Fourth Quarter and the Financial Year ended on March 31 2025. The Board of Directors of the company in its meeting held today i.e., on May 12, 2025 has : approved the Audited Standalone Financial Results of the company for the fourth quarter and the financial year ended on 31st March 2025 and the Audited Standalone Financial Statement for the financial year ended on 31st March 2025 along with Audit Report. approved the re-appointment of Mr. Dilip Vishnu Acharekar (DIN: 08849689) as an independent director of the Company. recommended the appointment of M/s. P S Rao & Associates, Company Secretaries as the Secretarial Auditor of the Company for a period of 5 consecutive years for the approval of the shareholders at the ensuing Annual General Meeting. (As Per BSE Announcement Dated on: 12/05/2025) | ||
| Board Meeting | 12 Feb 2025 | 4 Feb 2025 |
| Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the unaudited standalone financial results of the company for the third quarter ended on December 31 2024 along with limited review report. The Board of Directors of the company in its meeting held today Le., on February 12, 2025 has considered and approved Un-audited Standalone Financial Results along with limited review report of the Company for the third quarter and nine months ended on December 31, 2024. This is to inform you that the Board of Directors in their meeting held on Wednesday, February 12, 2025 has considered and approved un-audited standalone financial results along with limited review report of the company for the third quarter and nine months ended on December 31, 2024. (As Per BSE Announcement Dated on 12/02/2025) | ||
| Board Meeting | 13 Nov 2024 | 5 Nov 2024 |
| Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve the unaudited standalone financial results of the Company for the second quarter and half-year ended on 30th September 2024 along with the Limited Review Report. This is to inform that the Board of Directors in its meeting held on Wednesday, i.e November 13,2024 has: Considered and approved un-audited standalone financial results of the company for the second quarter and half-year ended on 30th September, 2024. Noted the resignation of Mr. Bhaskara Reddy Karna from the office of Independent Director w.e.f the conclusion of the meeting The Board of Directors of the company in its meeting held today i.e., on November 13, 2024 has : Considered and approved Un-audited Standalone Financial Results of the Company for the second quarter and half year ended on 30th September, 2024. Noted the resignation of Mr. Bhaskara Reddy Karna (DIN: 08961904) from the office of Independent Director w.e.f the conclusion of the Board Meeting (As per BSE Announcement Dated on 13/11/2024) | ||
| Board Meeting | 13 Aug 2024 | 31 Jul 2024 |
| Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve The unaudited standalone financial results of the Company for the first quarter ended on 30th June 2024 along with the Limited Review Report. The Board of Directors of the company in its meeting held today i.e., on August 13, 2024 has considered and approved the following: Unaudited Standalone Financial Results of the company for the First Quarter ended on June 30, 2024 along with the Limited Review Report submitted by the Statutory Auditors. (As per BSE Announcement dated on 13/08/2024) | ||
| Board Meeting | 29 May 2024 | 21 May 2024 |
| Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the audited standalone financial results of the Company for the 4th quarter and the financial year ended on March 31 2024 The Board of Directors of the company in its meeting held today i.e., on May 29, 2024 has : Considered and approved Audited Standalone Financial Results of the Company for the 4th .... Read More.. The Board of Directors of the company in its meeting held today i.e. , on May 29, 2024 has : Taken note of resignation of Mr. Satish Pandurang Samant (DIN : 10294920) from the office of Executive Director w.e.f May 29, 2024. Approved the resignation of Mr. Satish Pandurang Samant (DIN : 10294920) from the office of Chief Executive Officer w.e.f May 29, 2024. Read less.. The Board of Directors of the company in its meeting held today i.e. , on May 29, 2024 has : Approved the resignation of Mr. Satish Pandurang Samant (DIN : 10294920) from the office of Chief Executive Officer w.e.f May 29, 2024. Read less.. (As Per BSE Announcement Dated on 29.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
